Abiraterone Acetate to Lower Androgens in Women With Classic 21-Hydroxylase Deficiency

CONTEXT: Chronic supraphysiological glucocorticoid therapy controls the androgen excess of 21-hydroxylase deficiency (21OHD) but contributes to the high prevalence of obesity, glucose intolerance, and reduced bone mass in these patients. Abiraterone acetate (AA) is a prodrug for abiraterone, a poten...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Auchus, Richard J., Buschur, Elizabeth O., Chang, Alice Y., Hammer, Gary D., Ramm, Carole, Madrigal, David, Wang, George, Gonzalez, Martha, Xu, Xu Steven, Smit, Johan W., Jiao, James, Yu, Margaret K.
Formato: Artigo
Lenguaje:Inglês
Publicado: Endocrine Society 2014
Materias:
Endocrine Care
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4121028/
https://ncbi.nlm.nih.gov/pubmed/24780050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-1258
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares